BONUS BIOGROUP

Bonus BioGroup (TASE: BONS) is a product-focused biotechnology company applying proprietary, innovative technology to supply tissue-regenerating viable bone grafts. It is a pioneer in developing cell therapy and tissue engineering products based on autologous bone implants that enable efficient bone transplantation and provide cell-based bone replacement for repairing bone lesions. Bonus BioGroup developed a novel method to grow unique 3D high-density bone grafts, based on multi-cell 3D cultures. This leads to bone implants which are available on demand, personalized to each patient, safer, cost-effective, and more efficient than any other solution available to date.